Infectious and Tropical Diseases Group (e-INTRO), IBSAL-CIETUS (Biomedical Research Institute of Salamanca-Research Center for Tropical Diseases at the University of Salamanca), Faculty of Pharmacy, University of Salamanca, Salamanca, Spain.
Servicio de Microbiología y Parasitología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
PLoS Negl Trop Dis. 2021 Feb 22;15(2):e0009197. doi: 10.1371/journal.pntd.0009197. eCollection 2021 Feb.
Crimean-Congo haemorrhagic fever (CCHF) is a widespread tick-borne viral disease caused by the Crimean-Congo haemorrhagic fever virus (CCHFV). CCHFV has been implicated in severe viral haemorrhagic fever outbreaks. During the summer of 2016, the first two cases with genotype III (Africa 3) were reported in Spain. The first objective of our study was to determine the presence of CCHFV among patients with febrile illness during the spring and summer periods in 2017 and 2018. Finally, we perform a phylogenetic analysis to determine the genotype of the virus.
We prospectively evaluated patients aged 18 years and older who came to the emergency department at the Salamanca's University Hospital (HUS) with fever. Specific IgM and IgG antibodies against CCHFV by ELISA and one immunofluorescence assay against two different proteins (nucleoprotein and glycoprotein C) was done. Moreover, molecular detection by Real Time PCR was performed in all collected samples. A phylogenetic analysis was carried out to genetically characterize CCHFV detected in this study.
A total of 133 patients were selected. The mean age was 67.63 years and 60.9% were male. One-third of the patients presented an acute undifferentiated febrile illness. Three patients had anti-CCHFV IgG antibodies, suggesting a previous infection. One patient had anti-CCHFV IgM antibodies and a confirmatory RT-PCR. Phylogenetic analysis indicated that the virus corresponds to the European genotype V. This patient came to the emergency department at HUS in August 2018 presenting an acute febrile syndrome with thrombopenia and liver impairment.
We describe a new circulation of European genotype V CCHFV in Spain. Moreover, this study suggests that CCHFV is an identifiable cause of febrile illness of unknown origin in Spain. Thus, CCHF could be suspected in patients with fever, liver damage, and/or haemorrhagic disorders, particularly in people with risk activities who present in the spring or summer.
克里米亚-刚果出血热(CCHF)是一种广泛流行的蜱传病毒性疾病,由克里米亚-刚果出血热病毒(CCHFV)引起。CCHFV 与严重的病毒性出血热爆发有关。2016 年夏季,西班牙报告了首例两例基因型 III(非洲 3 型)病例。我们的研究的首要目标是确定 2017 年和 2018 年春季和夏季发热患者中是否存在 CCHFV。最后,我们进行了系统发育分析以确定病毒的基因型。
我们前瞻性评估了因发热而前往萨拉曼卡大学医院(HUS)急诊科就诊的年龄在 18 岁及以上的患者。通过 ELISA 和针对两种不同蛋白(核蛋白和糖蛋白 C)的一种免疫荧光测定法检测针对 CCHFV 的特异性 IgM 和 IgG 抗体。此外,对所有采集的样本进行实时 PCR 分子检测。进行了系统发育分析,以对本研究中检测到的 CCHFV 进行基因特征分析。
共选择了 133 名患者。平均年龄为 67.63 岁,60.9%为男性。三分之一的患者表现为急性未分化发热性疾病。有 3 例患者具有抗 CCHFV IgG 抗体,提示既往感染。有 1 例患者具有抗 CCHFV IgM 抗体和确认的 RT-PCR。系统发育分析表明,该病毒属于欧洲基因型 V。该患者于 2018 年 8 月因急性发热综合征伴血小板减少和肝损伤就诊于 HUS 急诊科。
我们描述了西班牙新型欧洲基因型 V CCHFV 的传播。此外,本研究表明 CCHFV 是西班牙不明原因发热性疾病的可识别病因。因此,在春季或夏季出现发热、肝损伤和/或出血性疾病的患者,尤其是有危险活动的患者,应怀疑 CCHF。